A study reported by the Daily Mail says certain low-cost tablets already used within the NHS could potentially help fight breast cancer. The report links breast cancer outcomes to differences in the gut microbiome, the community of bacteria involved in digesting food and producing chemical signals that can influence the body’s systems. According to the article, research has previously suggested that an imbalance in the gut microbiome is associated with worse breast cancer outcomes. The new study explores whether changing the gut microbiome with a treatment that is already available could improve outcomes for people with breast cancer. The Daily Mail articles emphasize that the tablets are already being used in the NHS, which could, in principle, support faster evaluation of their potential benefit for breast cancer compared with entirely new therapies. The summaries provided do not specify the exact tablet type, study size, methods, or whether results come from laboratory work, observational data, or clinical trials. The reported takeaway is that modifying the gut microbiome with an existing low-cost intervention is being investigated as a possible approach to improving breast cancer outcomes.